Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulvestaciclib + HP + ET in HR+/HER2+ Advanced Breast Cancer
NCT07716046Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Oct 2026
- Primary completion
- Aug 2030
01
Overview
A Phase 2 trial of fulvestrant in breast cancer, sponsored by Fudan University. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
fulvestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07716046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07716046.